EFLM

Survey promoted by the EFLM Task Group on Cardiac Markers

USE AND IMPLEMENTATION OF CARDIAC MARKERS IN ACUTE CORONARY SYNDROME AND HEART FAILURE AND THE STATUS OF LIPID AND LIPOPROTEIN TESTING

Deadline: 15 April 2019

The EFLM Task Group Cardiac Markers is performing a follow up survey on the use and implementation of cardiac markers in European countries, US and Canada. The results of the previous surveys (2006, 2010, 2013) have been published in several articles. The aim of this survey is to document the present situation of the use and implementation of cardiac markers of acute coronary syndrome and heart failure and to harmonize the situation on cardiac markers and their decision limits in European countries.

You can answer the questionnaire from any computer connected to the Internet. The questionnaire will take about 20 minutes to complete. The preliminary results of this survey will be presented during the EUROMDEDLAB in Barcelona in May 2019.

To answer the questionnaire, go to https://carmague.fi  and login with your email address. No password is used.

We thank you for your kind co-operation.

EFLM Task Group Cardiac Markers